| 영문 | graft versus host reaction | 한글 | 이식편대 숙주반응 |
|---|---|---|---|
| 설명 | 면역이란 자신의 것과 자신의 것이 아닌 것을 구분해서 자신의 것이 아닌 것을 공격하여 생물학적 활성을 없애거나 제거하는 것이다. 이 면역은 주로 혈액에 있는 세포에 의해서 이루어진다. 특히 림프구는 이 면역에 중추적인 역할을 하는 세포이다. 이식편대숙주반응이라는 것은 이식되어온 조직에 존재하는 타인의 혈구들이 숙주의 세포를 공격하는 것을 말한다. 즉 이식되어온 조직과 함께 들어온 혈구들이 이식을 받은 사람의 세포를 타인의 것으로 인지해서 공격하는 현상이다. 이것은 이식을 받은 사람의 면역상태가 정상적일 경우에는 일어나지 않는데 왜냐하면 면역상태가 정상일 경우에는 이식되어온 장기와 더불어 들어온 타인의 혈구들을 이식을 받은 사람의 혈구가 타인의 것으로 인지해서 공격을 하고 숫적으로 유리하여 모두 죽일 수가 있기 때문이다. |
||
| CT | calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ... |
|---|---|
| ET | educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e... |
| LR | labeled release; laboratory references; laboratory report; labor room; lactated Ringer [solution]; l... |
| ABE | acute bacterial endocarditis; American Board of Endodontics; botulism equine trivalent antitoxin |
| ACC | accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst... |
| normal antitoxin | Serum that is capable of neutralizing an equivalent quantity of a normal toxin solution. (05 Mar 2000) |
|---|---|
| despeciated antitoxin | An antitoxic serum treated in an appropriate manner to alter the species-specific protein, so that a person sensitised to the animal protein is not likely to have a serious reaction when the antitoxin is administered. (05 Mar 2000) |
| diphtheria antitoxin | An equine antitoxin against the toxin of corynebacterium diphtheriae, used for the treatment of diphtheria. It is to be differentiated from diphtheria toxoid which is used for the prevention of diphtheria. (12 Dec 1998) |
| diphtheria antitoxin unit | The antitoxin activity of 0.0628 mg standard diphtheria antitoxin. (05 Mar 2000) |
| dysentery antitoxin | Antitoxin specific for the neurotoxin of Shigella dysenteriae. (05 Mar 2000) |
| tetanus antitoxin | Antitoxin specific for the toxin of Clostridium tetani. (05 Mar 2000) |
| tetanus antitoxin unit | The antitoxin activity of 0.3094 mg of standard tetanus antitoxin. (05 Mar 2000) |
| tetanus-perfringens antitoxin | An antitoxin prepared from animals immunised against the toxins of Clostridium tetani and C. Perfringens (C. Welchii). (05 Mar 2000) |
| animal toxin | <pharmacology> Any poisonous substance (including but not limited to venom) produced by an animal. (11 May 1997) |
| anthrax toxin | A culture filtrate of Bacillus anthracis containing an exotoxin with at least three different antigenically distinct components: oedema factor, lethal factor, and protective antigen. Synonym: Bacillus anthracis toxin. (05 Mar 2000) |
| Bacillus anthracis toxin | A culture filtrate of Bacillus anthracis containing an exotoxin with at least three different antigenically distinct components: oedema factor, lethal factor, and protective antigen. Synonym: Bacillus anthracis toxin. (05 Mar 2000) |
| bacterial toxin | Any intracellular or extracellular toxin formed in or elaborated by bacterial cells. (05 Mar 2000) |
| bee toxin | The toxin delivered by a bee sting; contains three active principles: biogenic amines, active peptides, and certain hydrolytic enzymes. (05 Mar 2000) |
| botulinum toxin | <protein> Neurotoxin (50 kD, 7 distinct serotypes) produced by certain strains of Clostridium botulinum. The bacterium produces the toxin as a complex with a haemagglutinin that prevents toxin inactivation in the gut. Proteolysis in the body results in cleavage into two fragments A and B. B binds to gangliosides and may stimulate the endocytosis of fragment A. See: synaptobrevin, tetanus toxin. (18 Nov 1997) |
| botulinum toxin type a | <chemical> A neurotoxin produced by clostridium botulinum. When consumed in contaminated food it can cause paralysis and death. In its purified form, it has been used in the treatment of blepharospasm and strabismus. Pharmacological action: neuromuscular agents. (12 Dec 1998) |